Treatment of Buerger’s Disease (Thromboangiitis Obliterans) With Autologous Adipose Tissue-Derived Mesenchymal Stem Cell: Report of Three Cases

F1000Research - United Kingdom
doi 10.12688/f1000research.20850.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Thromboangiitis Obliterans (Buerger’s Disease)—Current Practices

International Journal of Inflammation
AllergyImmunology
2013English

New Aspects of Thromboangiitis Obliterans (Von Winiwarter-Buerger’s Disease)

European Neurology
Neurology
1984English

Treatment for Canine Corneal Ulcer Using Adipose Tissue-Derived Mesenchymal Stem Cell Therapy - Case Report

2019English

Case Report: Exploratory Treatment With Multiple Intravenous Infusion of the Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Diamond-Blackfan Anemia Patient

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Treatment of Severe Therapy-Resistant Acute Graft-Versus-Host Disease With Human Adipose Tissue-Derived Mesenchymal Stem Cells

Bone Marrow Transplantation
TransplantationHematology
2006English

Thromboangiitis Obliterans (Buerger's Disease)

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2006English

Properties of Hepatocyte-Like Cell Clusters From Human Adipose Tissue-Derived Mesenchymal Stem Cells

Tissue Engineering - Part C: Methods
MedicineBioengineeringBiomedical Engineering
2010English

Thromboangiitis Obliterans

Current Treatment Options in Rheumatology
RheumatologyAllergyImmunology
2016English

Epidural Fat-Derived Mesenchymal Stem Cell: First Report of Epidural Fat-Derived Mesenchymal Stem Cell

Asian Spine Journal
SurgeryOrthopedicsSports Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy